Latest Manufacturing Processes News

Amaero has resumed titanium powder production following a six-week safety-driven pause, implementing extensive facility and process upgrades to enhance operational safety and support future growth.

Noxopharm has taken a key regulatory step by requesting a pre-IND meeting with the US FDA for its autoimmune drug candidate SOF-SKN, aiming to smooth the path for clinical development and boost its commercial appeal.

Mesoblast has drawn US$50 million from a new five-year facility that reduces its interest burden and retires expensive short-term debt, strengthening its financial position ahead of commercial expansion.

Li-S Energy has secured ISO 9001:2015 certification for its lithium foil production in Geelong and completed its first commercial shipment to a leading Australian battery research institution, marking a key step in establishing a sovereign lithium foil supply chain.

Independent U.S. Army and WMTR testing confirms IperionX's Ti-6Al-4V fasteners outperform high-strength Grade 8 steel in torque-to-yield and tensile strength, underpinning a secure domestic titanium supply chain.

PolyNovo has completed its pivotal US clinical trial report for NovoSorb BTM and adjusted its FDA Premarket Approval submission timeline to late 2026 to incorporate updated regulatory requirements and additional data.

ClearVue Technologies has inked a manufacturing and distribution agreement with Aria Glass Industries, marking a major step into India’s booming construction sector backed by a US$240 million investment.

AnteoTech has secured independent validation of its Ultranode™ 95 silicon anode in commercial-format battery cells, demonstrating over 40% higher energy density and strong cycle life, advancing its push into the growing drone battery market.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Weebit Nano has reached a crucial 2026 target as two customers tape-out chip designs incorporating its ReRAM technology, with one already showing a working prototype. This progress marks a significant step towards mass production and commercialisation of its advanced memory solutions.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.

Firebird Metals has locked in a purpose-built industrial facility in Osborne Park, Perth, to house its pioneering Australian Demonstration Plant, the only fully integrated manganese concentrate-to-cathode active material facility outside China.